Amphastar Says Rivals' Patent Loss Is Antitrust Ammo
Amphastar Pharmaceuticals Inc. has told a Massachusetts federal judge that a chunk of its antitrust suit alleging two rivals boxed it out of the market for generic blood thinners has already...To view the full article, register now.
Already a subscriber? Click here to view full article